The drug market in the French African Region (French West Africa) with a turnover of more than EUR 900 million is expanding (evolution to 5% on 2019)
The need for quality medicines accessible to the population ,in this area is important but the national production are very low or inexistant
Therefore real opportunities available to pharmaceutical and para-pharmaceutical firms.
Considered as an area, made of 17 countries (Côte d'ivoire, Sénégal, Cameroun, Mali, Gabon, Mauritanie, Congo, RD Congo, Burkina-Faso, Togo, Bénin, Niger, Guinée, Rwanda, Burundi, Tchad, République de Centrafrique), with different cultures , different structuring of health services, different business environment and different therapeutic approaches .
Entering this market therefore requires a detailed knowledge of these particularities .
DIREP offers to put its expertise